IL6 and breast cancer: Results presented here demonstrate that NF-κB- and IL-6-dependent signaling pathways play essential roles in macrophage-mediated induction of endocrine resistance in ER+ breast cancer cells, and the consequent ability of these cells to proliferate in estradiol-independent manner.